Updated in 2025-10
.
ADC
| Target | Drug Name | Code | Approved Time | Company | Partner | ADC Design |
| HER2 ADC | Disitamab Vedotin | RC48 | 2021-06 | RameGen | LO: Seagen | Payload: MMAE Linker: MC-VC-PABC DAR: 3.5 |
| HER2 ADC | Trastuzumab Rezetecan | SHR-A1811 | 2025-05 | Hengrui | Payload: TOPO1 Linker: GGFG DAR: 6 | |
| HER2 ADC | 2025-10 | Kelun | Payload: MMAF Linker: K-lock-Va1-OI-PABC DAR: 2 | |||
| TROP2 ADC | Sacituzumab Tirumotecan | 2024-11 | Kelun | Payload: TOPO1 Linker: CL2A DAR: 7.4 | ||
| EGFR ADC | Cetuximab Sarotalocan | MRG003 | 2025-10 | Lepu | Payload: MMAE Linker: MC-VC-PABC DAR: 3.8 | |
